Your search returned 59 studies. (Get alerts for new studies):
- Phase 1b Trial of RAD001 in Patients With Operable Non-Small Cell Lung Cancer (NSCLC)
Conditions: Lung Cancer
1 Location available
- Erlotinib in Patients With Resected, Early Stage NSCLC With Confirmed Mutations in the EGFR
Conditions: Non-small Cell Lung Cancer
8 Locations available
- Vorinostat in Combination With Palliative Radiotherapy for Patients With Non-Small Cell Lung Cancer
Conditions: Non-Small Cell Lung Cancer (NSCLC)
1 Location available
- Study of Panobinostat in Combination With Sorafenib in Kidney or Lung Cancers
Conditions: Renal Cancer - Non Small Cell Lung Cancer (NSCLC)
1 Location available
- Feasibility of Using Real-time Cine-MRI for Treating Moving & Deforming Tumors
Conditions: Pancreatic Cancer - Liver Cancer - Lung Cancer - Lung Cancer Non-Small Cell Cancer (NSCLC) - Lung Cancer Small Cell Lung Cancer (SCLC) - Hepatobiliary Cancers - Hepatobiliary Cancers Liver - Hepatobiliary Cancers Hepatocellular Carcinoma (Hepatoma) - Hepa
1 Location available
- Study of PX-866 and Docetaxel in Solid Tumors
Conditions: Non Small Cell Lung Cancer (NSCLC) - Squamous Cell Carcinoma of the Head and Neck (SCCHN)
28 Locations available
- Phase II Study of Cabazitaxel-XRP6258 in Advanced Non-Small Cell Lung Cancer
Conditions: Non-small Cell Lung Cancer (NSCLC) - Stage IV NSCLC - Metastatic NSCLC
1 Location available
- Study of Outcomes of Radiofrequency Ablation of Lung Tumors
Conditions: NSCLC - Pulmonary Metastases
1 Location available
- Erlotinib With or Without Hydroxychloroquine in Chemo-Naive Advanced NSCLC and (EGFR) Mutations
Conditions: Non-small Cell Lung Cancer
4 Locations available
- Pazopanib + Vinorelbine in Non Small Cell Lung Cancer (NSCLC) and Breast Cancer
Conditions: Metastatic Non Small Cell Lung Cancer - Metastatic Breast Cancer
1 Location available
- Proton Beam Radiation With Concurrent Chemotherapy and Nelfinavir for Inoperable Stage III Non Small Cell Lung Cancer (NSCLC)
Conditions: Non Small Cell Lung Cancer
1 Location available
- A Window of Opportunity Trial of Afatinib In Early Stage Non-Small Cell Lung Cancer (NSCLC)
Conditions: Lung Cancer
1 Location available
- Adverse Event Toxicity Intervention Study To Evaluate The Effect Of Prophylactic Treatment And An Interrupted Dosing Schedule On The Incidence Of Adve
Conditions: Non Small Cell Lung Cancer (NSCLC)
8 Locations available
- A Study Of Oral PF-02341066, A c-Met/Hepatocyte Growth Factor Tyrosine Kinase Inhibitor, In Patients With Advanced Cancer
Conditions: Systemic Anaplastic Large-Cell Lymphoma - Neoplasms - Anaplastic Lymphoma Kinase, Human - NSCLC
9 Locations available
- Phase II Study of Dasatinib in Previously Treated Patients With Advanced NSCLC
Conditions: Non Small Cell Lung Cancer
3 Locations available
- Pharmacokinetic and Radiation Dosimetry Study Evaluating 99m TC-EC-DG SPECT/CT in Patients With Non-small Cell Lung Cancer (NSCLC)
Conditions: Non Small Cell Lung Cancer
2 Locations available
- A Study of Paclitaxel/Carboplatin With or Without IMC-3G3 in Previously Untreated Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)
Conditions: Non-Small Cell Lung Cancer
21 Locations available
- Trial of Bevacizumab and Ixabepilone for Advanced or Metastatic Non-small Cell Lung Cancer (NSCLC)
Conditions: Non-squamous Non-small Cell Lung Cancer
1 Location available
- Effect of GTx-024 on Muscle Wasting in Patients With Non-Small Cell Lung Cancer (NSCLC) on First Line Platinum
Conditions: Muscle Wasting - Non-Small Cell Lung Cancer
30 Locations available
- GRN1005 in Non-Small Cell Lung Cancer (NSCLC) Patients With Brain Metastases (GRABM-L)
Conditions: Non-small Cell Lung Cancer (NSCLC) With Brain Metastases
6 Locations available
- Phase III Lucanix™ Vaccine Therapy in Advanced Non-small Cell Lung Cancer (NSCLC) Following Front-line Chemotherapy
Conditions: Lung Neoplasm - Carcinoma Non-small Cell Lung Cancer Stage IIIA - Carcinoma Non-small Cell Lung Cancer Stage IIIB - Carcinoma Non-small Cell Lung Cancer Stage IV
50 Locations available
- Erlotinib Therapy and Subsequent Development of Mechanisms of Secondary Resistance in Patients With NSCLC
Conditions: Non-small Cell Lung Cancer
1 Location available
- A Study of Cisplatin + Pemetrexed + Avastin as First-Line Therapy in Patients With Advanced Non-Small Cell Lung Carcinoma (NSCLC)
Conditions: Non-Small Cell Lung Cancer
2 Locations available
- Utility of Routine Cervical Mediastinoscopy in Clinical Stage I Non-Small Cell Lung Cancer (NSCLC)
Conditions: Non-small Cell Lung Cancer
4 Locations available
- Endobronchial Ultrasound Versus Mediastinoscopy in Patients With Non-Small Cell Lung Cancer (NSCLC)
Conditions: Lung Cancer
1 Location available
- Phase 2 Study of Maintenance OSI-906 Plus Erlotinib (Tarceva®), or Placebo Plus Erlotinib in Patients With Nonprogression Following 4 Cycles of Platin
Conditions: Non-Small Cell Lung Cancer (NSCLC) With Nonprogression Following 4 Cycles of Platinum-based Chemotherapy
6 Locations available
- Pulmonary Interstitial Lymphography in Early Stage Lung Cancer
Conditions: Lung Cancer - Lung Cancer Non-Small Cell Cancer (NSCLC) - Lung Cancer Small Cell Lung Cancer (SCLC) - Mesothelioma
1 Location available
- Study of Erlotinib With or Without Investigational Drug (U3-1287) in Subjects With Advanced Non-small Cell Lung Cancer
Conditions: NSCLC (Advanced Non-small Cell Lung Cancer)
14 Locations available
- Study of Erlotinib (Tarceva®) in Combination With OSI-906 in Patients With Advanced Non-small Cell Lung Cancer (NSCLC) With Activating Mutations of th
Conditions: Non Small Cell Lung Cancer - NSCLC
18 Locations available
- A Study of Cesium-131 Brachytherapy Following Sub-Lobar Resection for Early Stage Non Small Cell Lung Cancer
Conditions: NSCLC - Non Small Cell Lung Cancer
1 Location available
- Seamless Study Of Stereotactic Lung Radiotherapy (SBRT) For Early Stage, Centrally Located, Non-Small Cell Lung Cancer (NSCLC) In Medically Inoperable
Conditions: Lung Cancer
1 Location available
- Phase III Study of the Effect of GTx-024 on Muscle Wasting in Patients With Non-Small Cell Lung Cancer (NSCLC)
Conditions: Muscle Wasting - Non Small Cell Lung Cancer
27 Locations available
- ARCHER 1009 : A Study Of PF-00299804 (Dacomitinib) Vs. Erlotinib In The Treatment Of Advanced Non-Small Cell Lung Cancer
Conditions: Non-Small Cell Lung Cancer (NSCLC)
55 Locations available
- Anamorelin HCl in the Treatment of Non-Small Cell Lung Cancer-Cachexia (NSCLC-C): An Extension Study (ROMANA 3)
Conditions: Cachexia - Non-Small Cell Lung Cancer
14 Locations available
- A Randomized, Open-label, Multicenter, Phase 3 Study to Compare the Efficacy and Safety of Eribulin With Treatment of Physician's Choice in Subjects W
Conditions: Non-Small Cell Lung Cancer (NSCLC)
13 Locations available
- Study of ABT-700 in Subjects With Advanced Solid Tumors
Conditions: Subjects With Advanced Solid Tumors (Including, But Not Limited to Gastric, Head and Neck, NSCLC, Colon, Mesothelioma and Triple Negative Breast Cancer).
3 Locations available
- Study to Assess Food Effect on Pharmacokinetics of Entinostat in Subjects With Breast Cancer or Non-Small Cell Lung Cancer
Conditions: Lung Cancer - Non Small Cell Lung Cancer (NSCLC) - Breast Cancer - ER+ Breast Cancer
2 Locations available
- Dasatinib and Erlotinib in Non-Small Cell Lung Cancer (NSCLC)
Conditions: Lung Cancer - Non-Small Cell Lung Cancer
1 Location available
- Pazopanib In Stage IIIB/IV NSCLC Lung Cancer After Progression on First Line Therapy Containing Bevacizumab
Conditions: Lung Cancer
3 Locations available
- STEREOtactic Radiation and Chemotherapy in Lung Cancer (STEREO)
Conditions: Non-small Cell Lung Cancer (NSCLC)
1 Location available
- Histology-based Consolidation Chemotherapy Following Concurrent Chemo-radiotherapy for Inoperable Stage III Non-small Cell Lung Cancer (NSCLC)
Conditions: Stage III Non-small Cell Lung Cancer
1 Location available
- Pharmacodynamic Separation of Pemetrexed and Erlotinib as Second-line Therapy in Patients With Advanced Non-small Cell Lung Cancer (NSCLC)
Conditions: Non-small Cell Lung Cancer
3 Locations available
- A Study In Patients Who Will Undergo Surgical Removal Of Non-Small Cell Lung Cancer To Evaluate Molecular Changes That Occur In Tumor Tissue After Sho
Conditions: Non-Small Cell Lung Cancer (NSCLC)
3 Locations available
- A Study of the HSP90 Inhibitor, STA-9090 in Subjects With Stage IIIB or IV Non-Small Cell Lung Cancer (NSCLC)
Conditions: Non Small Cell Lung Cancer
20 Locations available
- Carboplatin, Pemetrexed, and Panitumumab in Patients With Advanced Non-Squamous K-ras Wild Type NSCLC
Conditions: Non-Small-Cell Lung Cancer
11 Locations available
- Treatment of Locally Advanced Non-Small Cell Lung Cancer (NSCLC)
Conditions: Locally Advanced Non-small Cell Lung Cancer
3 Locations available
- A Phase I/II Study of Paclitaxel, Carboplatin and YM155 (Survivin Suppressor) in Subjects With Solid Tumors (Phase I) and Advanced Non-Small Cell Lung
Conditions: NSCLC - Solid Tumors
1 Location available
- Residual Hypermethylation in Early Stage Non-Small Cell Lung Cancer (NSCLC) As Part of Adjuvant Therapy and Preventive Strategy
Conditions: Lung Cancer - Non Small Cell Lung Carcinoma - Hypermethylation
1 Location available
- Stereotactic Boost for Locally Advanced Non-Small Cell Lung Cancer
Conditions: Non-small Cell Lung Cancer - Lung Cancer - NSCLC
1 Location available
- Cyclin Dependent Kinase (CDK)4/6 Inhibitor, PD0332991 in Advanced Non-small Cell Lung Cancer NSCLC.
Conditions: Non-small Cell Lung Cancer
2 Locations available
- Bavituximab Plus Carbo and Pemetrexed in Chemo-Naive Stage IV Non-Squamous Non-Small Cell Lung Cancer (NSCLC) Subjects
Conditions: Non Small Cell Lung Cancer (NSCLC)
2 Locations available
- Study of Cisplatin and Pemetrexed in Combination With Panobinostat in Solid Tumors
Conditions: Solid Tumors - Non-Small Cell Lung Cancer (NSCLC)
1 Location available
- Proton Radiotherapy for Patients With Non-Small Cell Lung Cancer (NSCLC)
Conditions: Lung Cancer
1 Location available
- Registry for Patients With Acquired Resistance to Small Molecule Kinase Inhibitors in Non-Small-Cell Lung Cancer
Conditions: Unresectable or Metastatic Non-small Cell Lung Cancer (NSCLC)
5 Locations available
- Utility of Endobronchial Ultrasound Guided Needle Biopsy in Early Stage Non- Small Cell Lung Cancer (NSCLC)
Conditions: Lung Cancer
1 Location available
- Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy
Conditions: Non-Small Cell Lung Cancer - Anemia - Cancer - Lung Cancer
163 Locations available
- Phase I Vorinostat Concurrent With Stereotactic Radiosurgery (SRS) in Brain Metastases From Non-Small Cell Lung Cancer
Conditions: Brain Cancer - Neoplasm Metastasis - Lung Cancer - Lung Cancer Non-Small Cell Cancer (NSCLC)
1 Location available
- Dose Escalation of Bevacizumab With Ambulatory Blood Pressure Monitoring in Patients With Advanced Non-squamous NSCLC
Conditions: Advanced Non-squamous Non-Small Cell Lung Cancer
1 Location available
- Dose Escalation Study of RAD001 in Combination w/Chemotherapy & Radiation in Patients With NSCLC
Conditions: Non-Small Cell Lung Cancer
1 Location available
|